Cleveland Clinic's 20th Annual ASH Review
2019 ASH Review on Newly Diagnosed Multiple Myeloma: VRD-Dara vs. VRD - What Is the Benefit of Daratumumab Addition to 3 Drug Regimen?
By
Cleveland Clinic's 20th Annual ASH Review
FEATURING
Faiz Anwer
By
Cleveland Clinic's 20th Annual ASH Review
FEATURING
Faiz Anwer
Login to view comments.
Click here to Login